These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17767974)

  • 21. Vietnam moves forward with harm reduction: an assessment of progress.
    Reid G; Higgs P
    Glob Public Health; 2011; 6(2):168-80. PubMed ID: 20155544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
    Limbu B
    Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse.
    Kumar MS; Virk HK; Chaudhuri A; Mittal A; Lewis G
    Int J Drug Policy; 2008 Apr; 19(2):148-58. PubMed ID: 18221862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
    Wozniak L; Prakash M; Taylor M; Wild TC
    Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in providing drug user treatment services in Russia: providers' views.
    Bobrova N; Rughnikov U; Neifeld E; Rhodes T; Alcorn R; Kirichenko S; Power R
    Subst Use Misuse; 2008; 43(12-13):1770-84. PubMed ID: 19016164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of how the health systems context shapes responses to the control of human immunodeficiency virus: case-studies from the Russian Federation.
    Atun RA; McKee M; Drobniewski F; Coker R
    Bull World Health Organ; 2005 Oct; 83(10):730-8. PubMed ID: 16283049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes].
    Trujols J; Iraurgi I; Solà I; Ballesteros J; Siñol N; Batlle F; Pérez de Los Cobos J
    Adicciones; 2010; 22(2):135-40. PubMed ID: 20549148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
    Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
    Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public opinion on needle and syringe programmes: avoiding assumptions for policy and practice.
    Treloar C; Fraser S
    Drug Alcohol Rev; 2007 Jul; 26(4):355-61. PubMed ID: 17564870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
    Gustafson DL; Goodyear L; Keough F
    Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving coverage and scale-up of HIV prevention, treatment and care for injecting drug users: moving the agenda forward.
    Sharma M; Burrows D; Bluthenthal RN
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S1-4. PubMed ID: 18262403
    [No Abstract]   [Full Text] [Related]  

  • 37. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-risk behavior among injecting or non-injecting drug users in Cape Town, Pretoria, and Durban, South Africa.
    Parry CD; Carney T; Petersen P; Dewing S; Needle R
    Subst Use Misuse; 2009; 44(6):886-904. PubMed ID: 19444728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Topical problems in the provision of the Russian Federation's population with sanitary-and-epidemiological well-being].
    Onishchenko GG
    Gig Sanit; 2008; (2):4-15. PubMed ID: 18507165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.